BASF Agricultural Solutions is advancing plans to commercialise Nemasphere™, a biotechnology trait designed to protect soybeans against damaging nematodes, after securing the approvals required in key export markets, including the European Union.
The company expects Nemasphere soybean varieties to launch in the US and Brazil from 2028 and believes the technology has peak annual sales potential exceeding €300 million.
Europe can import the technology, but not grow it
While the latest EU authorisation allows imports of soybeans containing the trait, BASF says European growers should not expect access to the technology themselves.
“Under the current regulatory framework, BASF does not view Nemasphere as a near-term opportunity for cultivation in Europe,” a spokesperson told AgNavigator.
“For the foreseeable future, its relevance to Europe would therefore be only through imported soybean products.”
That distinction matters because of what it says about Europe’s broader innovation landscape.
The EU consumes far more soy than it produces, relying heavily on imports for livestock feed. As a result, European supply chains may benefit from productivity-enhancing technologies developed overseas while the bloc’s own farmers remain unable to deploy them.
Yet the development still highlights a broader policy tension. While Europe has repeatedly sought to reduce its dependence on imported protein crops and strengthen domestic agricultural competitiveness, BASF’s comments suggest that some advanced crop technologies continue to face significant barriers to cultivation within the bloc.
A breakthrough trait with no European pathway
BASF describes Nemasphere as the first biotechnology trait providing resistance to soybean nematodes, pests estimated to cause around $4.5 billion in annual crop losses across Brazil and the US.
According to the company, the trait delivers up to 90% control of key plant-parasitic nematodes and has increased soybean yields by an average of up to 10% in field trials. BASF also says soybean crops carrying the trait improved the performance of subsequent cotton and corn crops in Brazilian rotations affected by root lesion nematodes.
“Today’s tools for nematode control are reaching their limits, and I’m proud that our teams have developed a breakthrough trait innovation with a new protection mechanism,” said Melanie Bausen-Wiens, member of the management board of BASF Agricultural Solutions responsible for technology.
“By acting from within the plant, Nemasphere addresses a persistent threat that often remains invisible above ground and can help farmers protect significant yield potential throughout the season and sustain field productivity over time.”
The launch varieties will combine Nemasphere with the Enlist E3® soybean trait platform through a licensing agreement with Vylor and M.S. Technologies, with commercial introductions planned from 2028.
Wider implications for European agriculture
BASF acknowledged that Nemasphere is unlikely to be the only biotech innovation facing regulatory barriers in Europe.
“Under the current regulatory framework, we see limited near-term opportunity for broader cultivation of biotech traits in Europe and BASF will continue to monitor the regulatory environment and evaluate opportunities where there is a clear farmer need and a viable regulatory pathway,” the spokesperson said.
The result is a familiar paradox. Europe is willing to approve imports of crops containing advanced biotech traits developed and grown elsewhere, while offering little prospect that its own farmers will gain access to the same innovations.
For BASF, Nemasphere is a key part of its Seed Solutions growth strategy. For Europe, however, the announcement raises a broader question: if a trait marketed as the first biotechnology solution to a major pest challenge cannot find a pathway to cultivation in the EU, what does that mean for the next generation of crop biotech innovations?




